id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2011-N-0898-0001,FDA,FDA-2011-N-0898,Applications for Food and Drug Administration Approval to Market New Drug: Revision of Postmarketing Reporting Requirements; Discontinuance,Rule,Notice of Interim Rule,2011-12-19T05:00:00Z,2011,12,2011-12-19T05:00:00Z,2012-02-18T04:59:59Z,2011-12-19T16:11:43Z,2011-32354,0,0,0900006480f85979